It should be noted that the ATLAS patient population had almost no squamous cell carcinoma, in contrast to the populations of the JMEN pemetrexed trial and the SATURN erlotinib trial.
值得注意的是ATLAS试验纳入的绝大多数病人为非鳞状细胞癌，不同于培美曲赛的JMEN试验和厄洛替尼的SATURN试验。
It should be noted that the ATLAS patient population had almost no squamous cell carcinoma, in contrast to the populations of the JMEN pemetrexed trial and the SATURN erlotinib trial.
值得注意的是ATLAS试验纳入的绝大多数病人为非鳞状细胞癌，不同于培美曲赛的JMEN试验和厄洛替尼的SATURN试验。
应用推荐